Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AIV1
Term | Name | Level | Count |
---|---|---|---|
GO:0000154 | rRNA modification | 6 | 12 |
GO:0000455 | enzyme-directed rRNA pseudouridine synthesis | 8 | 12 |
GO:0001522 | pseudouridine synthesis | 6 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006364 | rRNA processing | 8 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016072 | rRNA metabolic process | 7 | 12 |
GO:0031118 | rRNA pseudouridine synthesis | 7 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:0030490 | maturation of SSU-rRNA | 9 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0106388 | 18S rRNA aminocarboxypropyltransferase activity | 4 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140102 | catalytic activity, acting on a rRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901681 | sulfur compound binding | 2 | 12 |
GO:1904047 | S-adenosyl-L-methionine binding | 3 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 271 | 275 | PF00656 | 0.738 |
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.466 |
CLV_NRD_NRD_1 | 236 | 238 | PF00675 | 0.633 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.769 |
CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 236 | 238 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.410 |
DEG_SCF_FBW7_1 | 81 | 88 | PF00400 | 0.324 |
DEG_SPOP_SBC_1 | 25 | 29 | PF00917 | 0.701 |
DOC_CKS1_1 | 82 | 87 | PF01111 | 0.290 |
DOC_CYCLIN_RxL_1 | 215 | 226 | PF00134 | 0.601 |
DOC_CYCLIN_RxL_1 | 65 | 76 | PF00134 | 0.307 |
DOC_MAPK_gen_1 | 61 | 71 | PF00069 | 0.288 |
DOC_USP7_MATH_1 | 270 | 274 | PF00917 | 0.736 |
DOC_WW_Pin1_4 | 283 | 288 | PF00397 | 0.505 |
DOC_WW_Pin1_4 | 81 | 86 | PF00397 | 0.290 |
DOC_WW_Pin1_4 | 89 | 94 | PF00397 | 0.290 |
LIG_14-3-3_CanoR_1 | 123 | 127 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 73 | 77 | PF00244 | 0.417 |
LIG_Actin_WH2_2 | 59 | 75 | PF00022 | 0.390 |
LIG_BIR_III_2 | 115 | 119 | PF00653 | 0.347 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.468 |
LIG_eIF4E_1 | 206 | 212 | PF01652 | 0.295 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.367 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.396 |
LIG_FHA_1 | 86 | 92 | PF00498 | 0.375 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.564 |
LIG_LIR_Nem_3 | 108 | 114 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.361 |
LIG_MYND_1 | 127 | 131 | PF01753 | 0.290 |
LIG_Pex14_1 | 175 | 179 | PF04695 | 0.252 |
LIG_Rb_LxCxE_1 | 145 | 164 | PF01857 | 0.290 |
LIG_SH2_CRK | 141 | 145 | PF00017 | 0.290 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.449 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.624 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.290 |
LIG_SUMO_SIM_anti_2 | 102 | 108 | PF11976 | 0.353 |
LIG_SUMO_SIM_anti_2 | 156 | 161 | PF11976 | 0.405 |
LIG_TRAF2_1 | 275 | 278 | PF00917 | 0.723 |
MOD_CDK_SPxxK_3 | 89 | 96 | PF00069 | 0.410 |
MOD_CK1_1 | 249 | 255 | PF00069 | 0.534 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.349 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.319 |
MOD_CK2_1 | 239 | 245 | PF00069 | 0.629 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.656 |
MOD_Cter_Amidation | 260 | 263 | PF01082 | 0.513 |
MOD_Cter_Amidation | 59 | 62 | PF01082 | 0.290 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.410 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.437 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.375 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.353 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.608 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.628 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.665 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.720 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.305 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.410 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.478 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.318 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.361 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.651 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.775 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.732 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.304 |
MOD_N-GLC_2 | 56 | 58 | PF02516 | 0.347 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.548 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.410 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.365 |
MOD_NEK2_2 | 175 | 180 | PF00069 | 0.285 |
MOD_NEK2_2 | 246 | 251 | PF00069 | 0.470 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.410 |
MOD_PKA_2 | 142 | 148 | PF00069 | 0.305 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.419 |
MOD_PKB_1 | 16 | 24 | PF00069 | 0.468 |
MOD_PKB_1 | 237 | 245 | PF00069 | 0.444 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.290 |
MOD_Plk_1 | 197 | 203 | PF00069 | 0.394 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.184 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.299 |
MOD_ProDKin_1 | 283 | 289 | PF00069 | 0.504 |
MOD_ProDKin_1 | 81 | 87 | PF00069 | 0.290 |
MOD_ProDKin_1 | 89 | 95 | PF00069 | 0.290 |
TRG_DiLeu_BaLyEn_6 | 125 | 130 | PF01217 | 0.290 |
TRG_DiLeu_BaLyEn_6 | 67 | 72 | PF01217 | 0.290 |
TRG_ER_diArg_1 | 236 | 239 | PF00400 | 0.595 |
TRG_NES_CRM1_1 | 151 | 165 | PF08389 | 0.410 |
TRG_NLS_MonoExtN_4 | 118 | 124 | PF00514 | 0.410 |
TRG_Pf-PMV_PEXEL_1 | 218 | 223 | PF00026 | 0.619 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKZ2 | Leptomonas seymouri | 84% | 100% |
A0A0S4JEU2 | Bodo saltans | 64% | 100% |
A0A1X0NUA5 | Trypanosomatidae | 65% | 100% |
A0A3S7X5P4 | Leishmania donovani | 83% | 99% |
A0A422NB90 | Trypanosoma rangeli | 67% | 86% |
A4I818 | Leishmania infantum | 82% | 99% |
D0AA84 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9B2X6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 99% |
Q10409 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 43% | 100% |
Q12094 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 39% | 94% |
Q4Q580 | Leishmania major | 81% | 100% |
Q9UJK0 | Homo sapiens | 39% | 94% |
V5BG92 | Trypanosoma cruzi | 65% | 100% |